Clinical Trials Directory

Trials / Completed

CompletedNCT03980392

South Korean Study to Prevent Cognitive Impairment and Protect Brain Health Through Lifestyle Intervention

A Randomized Controlled Study to Evaluate Applicability of Korean Multidomain Intervention Program in the South Korean Study to Prevent Cognitive Impairment and Protect Brain Health Through Lifestyle Intervention

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
152 (actual)
Sponsor
Inha University Hospital · Academic / Other
Sex
All
Age
60 Years – 79 Years
Healthy volunteers
Accepted

Summary

This study evaluates acceptability and efficacy of multidomain intervention program to prevent cognitive impairment and protect brain health in Korean at-risk elderly. A third of participants will receive facility-based intervention for 6 months, a third will receive home-based intervention for 6 months, and a third is waiting list controls.

Detailed description

Despite extensive research in the field of Alzheimer's disease (AD), no treatment has yet been developed to modify the progression of AD. Therefore, it is important to manage vascular and metabolic risk factors, to eat healthy foods, to exercise, and to participate in social activities to prevent dementia. The FINGER study showed that the multi-domain intervention program is effective to prevent cognitive impairment and disability in elderly. In South Korea, exercise and leisure programs, and brain activity for the elderly also have been conducted in welfare centers and public health centers. However, there are not enough programs that have proven effective in the studies. So the investigators would like to develop a multi-domain intervention program and investigate applicability and efficacy before a large-scale randomized controlled trial.

Conditions

Interventions

TypeNameDescription
OTHERMultidomain intervention programMultidomain intervention program for physical exercise, cognitive training, nutrition, vascular and metabolic risk controls, and motivation

Timeline

Start date
2019-05-29
Primary completion
2020-02-14
Completion
2020-02-25
First posted
2019-06-10
Last updated
2021-03-04

Locations

6 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03980392. Inclusion in this directory is not an endorsement.